Align Technology Q3 Earnings Call Highlights
Align Technology (ALGN) reported Q3 revenue decline but scanner placements grew by double digits, reaching over 157,000 units. International markets drove volume growth, with double-digit increases in Latin America, EMEA, and APAC. GAAP EPS was $1.90, up from $0.78 YoY. The company expects Q4 revenue of $1.0B-$1.02B and narrowed fiscal 2026 revenue outlook to $4.11B-$4.13B. CEO transition announced with Jennifer Davis set to take over on Dec. 31.
How this was made

The 30-second read
Why it matters
Earnings beat and a $500M buyback plan provide a short‑term catalyst, while modest guidance may temper long‑term expectations.
Market read
Align's earnings and guidance impact the dental technology sector and related financing partners, with potential ripple effects on hardware suppliers.
What to watch
Potential headwinds from lower clear aligner ASPs and higher transportation costs may pressure margins if not offset by further efficiency gains.
Background
The article summarizes Align Technology's Q3 earnings call, highlighting financial results, operational metrics, and leadership change.
Ticker impact
Align Technology reported Q3 GAAP EPS of $1.90, GAAP operating margin of 16.7% and announced a $500M share repurchase plan for FY2026, plus a CEO transition.
likely modest upside as investors price in the buyback and earnings beat, tempered by guidance indicating slower revenue growth
The combination of better-than-expected earnings, a sizable share repurchase, and a clear guidance range provides a concrete catalyst for short-term price movement.
Market effects
Dental and orthodontic device sector may see increased investor interest due to Align's strong scanner placement growth and financing initiatives.
Positive outlook for North American DSO shipments could boost related equipment suppliers in the region.
Align's international volume growth signals broader demand for digital orthodontic solutions worldwide.
Counterpoint
Guidance suggests only low‑single‑digit revenue growth and a 1% price decline, which could limit upside despite the buyback.
Key entities
- companyAlign Technology
US‑listed dental device maker (NASDAQ:ALGN).
- executiveJoseph Hogan
Outgoing CEO of Align Technology.
- executiveJennifer Davis
CEO‑elect of Align Technology.


